Refine
Document Type
- Article (14)
- Doctoral Thesis (4)
Is part of the Bibliography
- no (18)
Keywords
- inflammation (18) (remove)
Institute
- Kliniken und Polikliniken für Innere Medizin (2)
- Institut für Biochemie (1)
- Institut für Community Medicine (1)
- Institut für Hygiene und Umweltmedizin (1)
- Institut für Immunologie u. Transfusionsmedizin - Abteilung Transfusionsmedizin (1)
- Institut für Klinische Chemie und Laboratoriumsmedizin (1)
- Institut für Mathematik und Informatik (1)
- Institut für Med. Biochemie u. Molekularbiologie (1)
- Institut für Pharmakologie (1)
- Institut für Pharmazie (1)
Publisher
- MDPI (5)
- Frontiers Media S.A. (4)
- Wiley (2)
- Dove Medical Press (1)
- SAGE Publications (1)
Around the world there are 33.5 million patients suffering from atrial fibrillation (AF) with an annual increase of 5 million cases. Most AF patients have an established form of an atrial cardiomyopathy. The concept of atrial cardiomyopathy was introduced in 2016. Thus, therapy of underlying diseases and atrial tissue changes appear as a cornerstone of AF therapy. Furthermore, therapy or prevention of atrial endocardial changes has the potential to reduce atrial thrombogenesis and thereby cerebral stroke. The present manuscript will summarize the underlying pathophysiology and remodeling processes observed in the development of an atrial cardiomyopathy, thrombogenesis, and atrial fibrillation. In particular, the impact of oxidative stress, inflammation, diabetes, and obesity will be addressed.